You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro ® (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Has Mounjaro® (tirzepatide) been compared with dulaglutide 3.0 mg or 4.5 mg in head-to-head trials?
Tirzepatide compared with dulaglutide 3.0 or 4.5 mg has not been studied.
See important safety information, including boxed warning, in the attached prescribing information.
Comparison With Dulaglutide 3 and 4.5 mg
There is no information on the use of tirzepatide compared with dulaglutide 3.0 or 4.5 mg because this comparison has not been studied.
Enclosed Prescribing Information
Date of Last Review: October 13, 2023